Mayo Clinic Southeastern Clinical Update in Nephrology, Hypertension and Kidney Transplantation 2021

MODULE 1: COVID-19
– How did we manage the crisis and what we have learned
Pablo Moreno Franco, M.D.
– COVID Associated AKI: The Experience from the Epicenter in NY
Andrew Bomback, M.D.
– COVID Management in the Kidney Transplant Patients: What have we learned?
Hani M. Wadei, M.D.
MODULE 2: STEM CELL RESEARCH
– Can We Treat Ischemic Nephropathy with Stem Cell Therapy?
Stephen C. Textor, M.D.
– Mesenchymal Stem Cell Therapy in Diabetic Nephropathy: From Bench to
Bedside
LaTonya J. Hickson, M.D.
– SGLT2 Inhibitors in Diabetic Kidney Disease
Nabeel Aslam, M.D.
MODULE 3: TRANSPLANT
– Diagnosis and Management of ABMR in 2021
Carrie A. Schinstock, M.D.
– Updates in Kidney Allocation: How Does it Affect Your Patient?
Martin L. Mai, M.D.
– Fraility Assessment in Kidney Transplant recipients: Fact or Fiction
Elizabeth C. Lorenz, M.D.
MODULE 4: ICU NEPHROLOGY
– How Fluid Therapy During Shock Resuscitation Impacts Kidney?
Kianoush B. Kashani, M.D., M.S.
– Medication Management for Patients on CRRT
Daniel A. Jackson, Pharm.D., R.Ph.
– Parenteral Nutrition for AKI/CKD Patients in the ICU
Mireille Hamdan MS, RD, LDN, CNSC
MODULE 5: POTPOURRI
– Secondary HTN: Update
Sandra J. Taler, M.D.
– What is New in PCKD
Michael A. Mao, M.D.
– Recurrent FSGS After Kidney Transplant
Hatem Amer, M.D.